AB

Ajay Bhushanlal Khushu

Active Director Director DIN 02594964
DIN 02594964 First appointment Jul 2014 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jul 2014
Shareholding value •••• Premium profile

About Ajay Bhushanlal Khushu

Data last updated:

Ajay Bhushanlal Khushu is a Director at Niyogi Enterprise Private Limited (since 2024), Director at Aculife Healthcare Private Limited (since 2014) and Director at Stericon Pharma Private Limited (since 2024). The companies operate in Financial Services, Pharma and Home & Lifestyle. The 3 current companies with reported revenue have a combined latest revenue of ₹11,358 Cr; the largest is Niyogi Enterprise Private Limited at ₹10,541 Cr (FY 2025). Earlier, Ajay Bhushanlal Khushu was a Director at Nirchem Cement Limited (from 2016).

DIN 02594964
Primary Designation Director
Industry Financial Services
First Appointment 28 Jul 2014
Oldest Company Age 36 yrs
Largest company Niyogi Enterprise Private Limited · ₹10,541 Cr (FY 2025)
Combined revenue ₹11,358 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Niyogi Enterprise Private Limited U51909GJ2019PTC106218
Director29 Feb 20242019₹10,541 Cr (FY 2025)Active
Aculife Healthcare Private Limited U24233GJ2014PTC080271
Director28 Jul 20142014₹648 Cr (FY 2025)Active
Stericon Pharma Private Limited U33201KA1990PTC011056
Director03 Apr 20241990₹169 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nirchem Cement Limited U26100MH2016PLC284338
Director02 Aug 20162016Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aculife Healthcare Private Limited
Nirchem Cement Limited
Niyogi Enterprise Private Limited
Stericon Pharma Private Limited
Premium access

Shareholding and investment profile for Ajay Bhushanlal Khushu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Bhushanlal Khushu

Ajay Bhushanlal Khushu currently holds 3 directorships: Niyogi Enterprise Private Limited (Director, since 29 Feb 2024, revenue ₹10,541 Cr (FY 2025)); Aculife Healthcare Private Limited (Director, since 28 Jul 2014, revenue ₹648 Cr (FY 2025)); Stericon Pharma Private Limited (Director, since 03 Apr 2024, revenue ₹169 Cr (FY 2025)).

Ajay Bhushanlal Khushu was first appointed on 28 Jul 2014 as Director at Aculife Healthcare Private Limited. The most recent appointment on record is 03 Apr 2024 at Stericon Pharma Private Limited.

The 3 current companies of Ajay Bhushanlal Khushu that report revenue have a combined latest revenue of ₹11,358 Cr: Niyogi Enterprise Private Limited ₹10,541 Cr (FY 2025); Aculife Healthcare Private Limited ₹648 Cr (FY 2025); Stericon Pharma Private Limited ₹169 Cr (FY 2025).

Ajay Bhushanlal Khushu held 1 earlier board appointment: Nirchem Cement Limited (Director, from 02 Aug 2016).

The current boards of Ajay Bhushanlal Khushu's companies include Dharaben Krunalbhai Patel (Niyogi Enterprise Private Limited), Hiren Karsanbhai Patel (Niyogi Enterprise Private Limited), Karsanbhai Patel Khodidas (Niyogi Enterprise Private Limited), Rakeshbhai Karsanbhai Patel (Niyogi Enterprise Private Limited), Amar Narendrabhai Shah (Aculife Healthcare Private Limited), Chinmay Rajesh Vasa (Aculife Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available